Shilanski & Associates’s CATALENT, INC. CTLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-13,368
Closed -$1.41M 123
2021
Q1
$1.41M Sell
13,368
-52
-0.4% -$5.8K 0.75% 44
2020
Q4
$1.4M Buy
13,420
+185
+1% +$17.9K 0.85% 41
2020
Q3
$1.13M Buy
13,235
+137
+1% +$11.6K 0.77% 39
2020
Q2
$960K Buy
13,098
+273
+2% +$18.5K 0.7% 46
2020
Q1
$666K Buy
12,825
+661
+5% +$36.1K 0.67% 49
2019
Q4
$685K Buy
12,164
+767
+7% +$39.1K 0.53% 58
2019
Q3
$543K Buy
+11,397
New +$612K 0.44% 61

Other funds holding CTLT

Shilanski & Associates's CTLT Position: Q2 2021 in Review

Shilanski & Associates sold out of CATALENT, INC. (CTLT) in Q2 2021, closing a stake of 13,368 shares — an estimated $1.41M sold.

Shilanski & Associates first reported a position in CTLT in Q3 2019 and held it in 7 quarters. The position peaked at $1.41M in Q1 2021. 509 funds tracked by Wall St. Rank hold CTLT as of Q2 2021.

  • Shilanski & Associates reported no remaining CATALENT, INC. position as of Q2 2021 after selling out during the quarter.
  • Shilanski & Associates sold 13,368 CATALENT, INC. shares in Q2 2021, an estimated $1.41M.
  • Shilanski & Associates first reported a position in CATALENT, INC. in Q3 2019 and held it in 7 quarters.
  • Shilanski & Associates's CATALENT, INC. position peaked at $1.41M in Q1 2021.
  • 509 funds tracked by Wall St. Rank held CATALENT, INC. as of Q2 2021.

Based on Shilanski & Associates's 13F filing for Q2 2021, filed 13 Aug 2021.